Structure

Physi-Chem Properties

Molecular Weight:  228.1
Volume:  226.298
LogP:  0.409
LogD:  1.348
LogS:  -1.304
# Rotatable Bonds:  5
TPSA:  68.15
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  1
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.589
Synthetic Accessibility Score:  3.153
Fsp3:  0.455
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.443
MDCK Permeability:  1.8299118892173283e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.059
Human Intestinal Absorption (HIA):  0.035
20% Bioavailability (F20%):  0.108
30% Bioavailability (F30%):  0.081

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.374
Plasma Protein Binding (PPB):  49.22415542602539%
Volume Distribution (VD):  1.261
Pgp-substrate:  50.681732177734375%

ADMET: Metabolism

CYP1A2-inhibitor:  0.018
CYP1A2-substrate:  0.777
CYP2C19-inhibitor:  0.013
CYP2C19-substrate:  0.366
CYP2C9-inhibitor:  0.01
CYP2C9-substrate:  0.246
CYP2D6-inhibitor:  0.023
CYP2D6-substrate:  0.379
CYP3A4-inhibitor:  0.06
CYP3A4-substrate:  0.306

ADMET: Excretion

Clearance (CL):  9.159
Half-life (T1/2):  0.667

ADMET: Toxicity

hERG Blockers:  0.023
Human Hepatotoxicity (H-HT):  0.043
Drug-inuced Liver Injury (DILI):  0.046
AMES Toxicity:  0.649
Rat Oral Acute Toxicity:  0.152
Maximum Recommended Daily Dose:  0.039
Skin Sensitization:  0.931
Carcinogencity:  0.188
Eye Corrosion:  0.006
Eye Irritation:  0.892
Respiratory Toxicity:  0.057

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC477803

Natural Product ID:  NPC477803
Common Name*:   4-(1,2,2-Trimethoxyethyl)benzene-1,2-diol
IUPAC Name:   4-(1,2,2-trimethoxyethyl)benzene-1,2-diol
Synonyms:  
Standard InCHIKey:  GJZGSHAHIYNSKQ-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C11H16O5/c1-14-10(11(15-2)16-3)7-4-5-8(12)9(13)6-7/h4-6,10-13H,1-3H3
SMILES:  COC(C1=CC(=C(C=C1)O)O)C(OC)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   10013990
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0002542] Benzylethers

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. Vanuatu islands n.a. PMID[10924170]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[11277766]
NPO20237 Poecillastra wondoensis Species Vulcanellidae Eukaryota n.a. n.a. n.a. PMID[14640526]
NPO20237 Poecillastra wondoensis Species Vulcanellidae Eukaryota n.a. depth of 25 m off the shore of Keomun Island, Korea 2004-AUG PMID[18407691]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. depth of 25 m off the shore of Keomun Island, Korea 2004-AUG PMID[18407691]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[18990572]
NPO33335 Jaspis sp. Species Ancorinidae Eukaryota n.a. n.a. n.a. PMID[8326327]
NPO20237 Poecillastra wondoensis Species Vulcanellidae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1087 Individual Protein Isocitrate lyase Candida albicans IC50 = 28.7 ug/ml PMID[18407691]
NPT2 Others Unspecified IC50 > 200 ug/ml PMID[18407691]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC477803 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9068 High Similarity NPC266045
0.8974 High Similarity NPC181969
0.8974 High Similarity NPC320987
0.8952 High Similarity NPC65942
0.8952 High Similarity NPC248307
0.8908 High Similarity NPC470804
0.8898 High Similarity NPC148615
0.8898 High Similarity NPC35071
0.8898 High Similarity NPC177475
0.8889 High Similarity NPC255675
0.8814 High Similarity NPC135961
0.879 High Similarity NPC307110
0.877 High Similarity NPC90318
0.875 High Similarity NPC476343
0.874 High Similarity NPC35731
0.874 High Similarity NPC470881
0.873 High Similarity NPC471505
0.873 High Similarity NPC254275
0.8718 High Similarity NPC221049
0.8718 High Similarity NPC175771
0.8678 High Similarity NPC209567
0.8661 High Similarity NPC6836
0.864 High Similarity NPC270849
0.864 High Similarity NPC26653
0.864 High Similarity NPC166040
0.8629 High Similarity NPC231607
0.8629 High Similarity NPC79715
0.8629 High Similarity NPC264900
0.8629 High Similarity NPC108659
0.8621 High Similarity NPC264558
0.8607 High Similarity NPC220598
0.8607 High Similarity NPC471693
0.8607 High Similarity NPC165375
0.8605 High Similarity NPC199459
0.8605 High Similarity NPC52277
0.8605 High Similarity NPC177035
0.8594 High Similarity NPC107478
0.8583 High Similarity NPC106739
0.8583 High Similarity NPC252833
0.8583 High Similarity NPC470270
0.8571 High Similarity NPC80600
0.8571 High Similarity NPC472024
0.856 High Similarity NPC148982
0.856 High Similarity NPC232880
0.8559 High Similarity NPC148055
0.8548 High Similarity NPC191037
0.8548 High Similarity NPC178284
0.8548 High Similarity NPC58607
0.8548 High Similarity NPC94179
0.8547 High Similarity NPC157338
0.8547 High Similarity NPC313193
0.8538 High Similarity NPC304152
0.8538 High Similarity NPC470413
0.8538 High Similarity NPC138738
0.8527 High Similarity NPC101624
0.8527 High Similarity NPC135777
0.8527 High Similarity NPC184938
0.8527 High Similarity NPC142547
0.8516 High Similarity NPC132895
0.8512 High Similarity NPC470414
0.85 High Similarity NPC311595
0.85 High Similarity NPC24474
0.8492 Intermediate Similarity NPC184092
0.8492 Intermediate Similarity NPC477294
0.8492 Intermediate Similarity NPC229784
0.8492 Intermediate Similarity NPC248355
0.8492 Intermediate Similarity NPC477293
0.8487 Intermediate Similarity NPC164386
0.8482 Intermediate Similarity NPC12278
0.848 Intermediate Similarity NPC292056
0.848 Intermediate Similarity NPC118533
0.848 Intermediate Similarity NPC476873
0.848 Intermediate Similarity NPC118787
0.848 Intermediate Similarity NPC165045
0.848 Intermediate Similarity NPC147821
0.848 Intermediate Similarity NPC111247
0.848 Intermediate Similarity NPC41706
0.848 Intermediate Similarity NPC183181
0.848 Intermediate Similarity NPC163332
0.848 Intermediate Similarity NPC319625
0.8468 Intermediate Similarity NPC194519
0.8468 Intermediate Similarity NPC148627
0.8455 Intermediate Similarity NPC473451
0.845 Intermediate Similarity NPC886
0.845 Intermediate Similarity NPC287597
0.845 Intermediate Similarity NPC34293
0.8448 Intermediate Similarity NPC173746
0.8448 Intermediate Similarity NPC156840
0.8448 Intermediate Similarity NPC8547
0.8448 Intermediate Similarity NPC257124
0.8443 Intermediate Similarity NPC49341
0.8438 Intermediate Similarity NPC473285
0.8425 Intermediate Similarity NPC275950
0.8417 Intermediate Similarity NPC309434
0.8413 Intermediate Similarity NPC11258
0.8413 Intermediate Similarity NPC245826
0.8413 Intermediate Similarity NPC282703
0.8413 Intermediate Similarity NPC184733
0.8413 Intermediate Similarity NPC21867
0.8413 Intermediate Similarity NPC128208
0.8413 Intermediate Similarity NPC474178
0.8413 Intermediate Similarity NPC45774
0.8413 Intermediate Similarity NPC302378
0.8413 Intermediate Similarity NPC252307
0.8413 Intermediate Similarity NPC129570
0.84 Intermediate Similarity NPC473960
0.8397 Intermediate Similarity NPC78363
0.8387 Intermediate Similarity NPC94276
0.8387 Intermediate Similarity NPC131747
0.8387 Intermediate Similarity NPC257682
0.8387 Intermediate Similarity NPC146355
0.8387 Intermediate Similarity NPC109822
0.8372 Intermediate Similarity NPC25821
0.8372 Intermediate Similarity NPC254398
0.8361 Intermediate Similarity NPC207613
0.8359 Intermediate Similarity NPC166168
0.8359 Intermediate Similarity NPC476345
0.8359 Intermediate Similarity NPC219677
0.8359 Intermediate Similarity NPC9912
0.8347 Intermediate Similarity NPC20674
0.8346 Intermediate Similarity NPC134405
0.8346 Intermediate Similarity NPC472711
0.8346 Intermediate Similarity NPC5851
0.8346 Intermediate Similarity NPC476385
0.8346 Intermediate Similarity NPC476968
0.8346 Intermediate Similarity NPC170844
0.8346 Intermediate Similarity NPC86030
0.8333 Intermediate Similarity NPC293619
0.8333 Intermediate Similarity NPC472350
0.8333 Intermediate Similarity NPC123526
0.8333 Intermediate Similarity NPC81515
0.8333 Intermediate Similarity NPC197316
0.8333 Intermediate Similarity NPC5428
0.8333 Intermediate Similarity NPC88640
0.8333 Intermediate Similarity NPC89105
0.8333 Intermediate Similarity NPC64141
0.8333 Intermediate Similarity NPC68092
0.8333 Intermediate Similarity NPC193666
0.8333 Intermediate Similarity NPC476383
0.8321 Intermediate Similarity NPC157554
0.8319 Intermediate Similarity NPC233669
0.8308 Intermediate Similarity NPC187194
0.8308 Intermediate Similarity NPC48863
0.8308 Intermediate Similarity NPC251981
0.8308 Intermediate Similarity NPC13745
0.8308 Intermediate Similarity NPC471883
0.8306 Intermediate Similarity NPC212176
0.8304 Intermediate Similarity NPC110764
0.8295 Intermediate Similarity NPC473924
0.8295 Intermediate Similarity NPC147616
0.8295 Intermediate Similarity NPC259742
0.8295 Intermediate Similarity NPC104077
0.8295 Intermediate Similarity NPC299144
0.8295 Intermediate Similarity NPC219671
0.8293 Intermediate Similarity NPC312675
0.8293 Intermediate Similarity NPC473853
0.8293 Intermediate Similarity NPC343720
0.8293 Intermediate Similarity NPC470212
0.8293 Intermediate Similarity NPC324571
0.8293 Intermediate Similarity NPC113865
0.8293 Intermediate Similarity NPC184651
0.8293 Intermediate Similarity NPC262156
0.8293 Intermediate Similarity NPC147654
0.8293 Intermediate Similarity NPC54872
0.8291 Intermediate Similarity NPC78918
0.8291 Intermediate Similarity NPC139617
0.8284 Intermediate Similarity NPC140502
0.8284 Intermediate Similarity NPC189115
0.8284 Intermediate Similarity NPC222433
0.8284 Intermediate Similarity NPC469559
0.8284 Intermediate Similarity NPC48309
0.8284 Intermediate Similarity NPC265648
0.8284 Intermediate Similarity NPC253878
0.8281 Intermediate Similarity NPC142985
0.8281 Intermediate Similarity NPC187998
0.8281 Intermediate Similarity NPC181079
0.8281 Intermediate Similarity NPC42300
0.8281 Intermediate Similarity NPC145305
0.8281 Intermediate Similarity NPC143483
0.8281 Intermediate Similarity NPC64201
0.8281 Intermediate Similarity NPC242807
0.8281 Intermediate Similarity NPC153739
0.8281 Intermediate Similarity NPC257582
0.8281 Intermediate Similarity NPC174495
0.8281 Intermediate Similarity NPC92164
0.8281 Intermediate Similarity NPC77040
0.8281 Intermediate Similarity NPC241522
0.8281 Intermediate Similarity NPC173308
0.8279 Intermediate Similarity NPC229401
0.8279 Intermediate Similarity NPC469702
0.8279 Intermediate Similarity NPC282409
0.8276 Intermediate Similarity NPC246358
0.8276 Intermediate Similarity NPC233731
0.8276 Intermediate Similarity NPC36108
0.8276 Intermediate Similarity NPC7097
0.8271 Intermediate Similarity NPC473799
0.8271 Intermediate Similarity NPC475530
0.8271 Intermediate Similarity NPC106944
0.8268 Intermediate Similarity NPC98631
0.8268 Intermediate Similarity NPC72529

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477803 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8448 Intermediate Similarity NPD228 Approved
0.8346 Intermediate Similarity NPD3027 Phase 3
0.8333 Intermediate Similarity NPD7266 Discontinued
0.8197 Intermediate Similarity NPD1357 Approved
0.8145 Intermediate Similarity NPD3705 Approved
0.7966 Intermediate Similarity NPD3022 Approved
0.7966 Intermediate Similarity NPD3021 Approved
0.7879 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD1613 Approved
0.7857 Intermediate Similarity NPD1091 Approved
0.771 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7698 Intermediate Similarity NPD9381 Approved
0.7698 Intermediate Similarity NPD9384 Approved
0.7634 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD1653 Approved
0.7603 Intermediate Similarity NPD9280 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD9622 Approved
0.7597 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD5283 Phase 1
0.7556 Intermediate Similarity NPD230 Phase 1
0.7438 Intermediate Similarity NPD2684 Approved
0.7424 Intermediate Similarity NPD9619 Approved
0.7424 Intermediate Similarity NPD9621 Approved
0.7424 Intermediate Similarity NPD9620 Approved
0.741 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD2978 Approved
0.7365 Intermediate Similarity NPD2977 Approved
0.7353 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7353 Intermediate Similarity NPD3620 Phase 2
0.7353 Intermediate Similarity NPD1558 Phase 1
0.7339 Intermediate Similarity NPD9377 Approved
0.7339 Intermediate Similarity NPD7843 Approved
0.7339 Intermediate Similarity NPD9379 Approved
0.7333 Intermediate Similarity NPD598 Approved
0.7333 Intermediate Similarity NPD601 Approved
0.7333 Intermediate Similarity NPD597 Approved
0.7324 Intermediate Similarity NPD6190 Approved
0.7305 Intermediate Similarity NPD6674 Discontinued
0.7304 Intermediate Similarity NPD2934 Approved
0.7304 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.7304 Intermediate Similarity NPD2933 Approved
0.7302 Intermediate Similarity NPD7157 Approved
0.7286 Intermediate Similarity NPD1375 Discontinued
0.7279 Intermediate Similarity NPD1130 Approved
0.7279 Intermediate Similarity NPD1136 Approved
0.7279 Intermediate Similarity NPD1132 Approved
0.7279 Intermediate Similarity NPD2674 Phase 3
0.7241 Intermediate Similarity NPD2859 Approved
0.7241 Intermediate Similarity NPD2860 Approved
0.7241 Intermediate Similarity NPD844 Approved
0.7239 Intermediate Similarity NPD2861 Phase 2
0.7239 Intermediate Similarity NPD9494 Approved
0.7227 Intermediate Similarity NPD846 Approved
0.7227 Intermediate Similarity NPD940 Approved
0.7226 Intermediate Similarity NPD3061 Approved
0.7226 Intermediate Similarity NPD3062 Approved
0.7226 Intermediate Similarity NPD3059 Approved
0.7222 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD290 Approved
0.7203 Intermediate Similarity NPD3020 Approved
0.7197 Intermediate Similarity NPD2983 Phase 2
0.7197 Intermediate Similarity NPD2982 Phase 2
0.7183 Intermediate Similarity NPD3060 Approved
0.7171 Intermediate Similarity NPD6234 Discontinued
0.7155 Intermediate Similarity NPD9296 Approved
0.7153 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1242 Phase 1
0.7143 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.7132 Intermediate Similarity NPD9545 Approved
0.7122 Intermediate Similarity NPD5314 Approved
0.7121 Intermediate Similarity NPD2981 Phase 2
0.7117 Intermediate Similarity NPD111 Approved
0.7111 Intermediate Similarity NPD3018 Phase 2
0.7101 Intermediate Similarity NPD4060 Phase 1
0.7101 Intermediate Similarity NPD825 Approved
0.7101 Intermediate Similarity NPD826 Approved
0.709 Intermediate Similarity NPD3094 Phase 2
0.708 Intermediate Similarity NPD3145 Approved
0.708 Intermediate Similarity NPD3144 Approved
0.7073 Intermediate Similarity NPD1358 Approved
0.7067 Intermediate Similarity NPD37 Approved
0.7063 Intermediate Similarity NPD4236 Phase 3
0.7063 Intermediate Similarity NPD4237 Approved
0.7055 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD5536 Phase 2
0.7045 Intermediate Similarity NPD3092 Approved
0.7034 Intermediate Similarity NPD288 Approved
0.7031 Intermediate Similarity NPD6671 Approved
0.7027 Intermediate Similarity NPD3687 Approved
0.7027 Intermediate Similarity NPD3686 Approved
0.7025 Intermediate Similarity NPD7054 Approved
0.7023 Intermediate Similarity NPD5126 Approved
0.7023 Intermediate Similarity NPD5125 Phase 3
0.7 Intermediate Similarity NPD823 Approved
0.7 Intermediate Similarity NPD817 Approved
0.7 Intermediate Similarity NPD1548 Phase 1
0.6992 Remote Similarity NPD968 Approved
0.6984 Remote Similarity NPD969 Suspended
0.6981 Remote Similarity NPD7472 Approved
0.6981 Remote Similarity NPD7074 Phase 3
0.6972 Remote Similarity NPD9570 Approved
0.697 Remote Similarity NPD3496 Discontinued
0.6962 Remote Similarity NPD7228 Approved
0.6962 Remote Similarity NPD3818 Discontinued
0.696 Remote Similarity NPD9380 Clinical (unspecified phase)
0.6954 Remote Similarity NPD1934 Approved
0.6942 Remote Similarity NPD291 Approved
0.694 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6937 Remote Similarity NPD6797 Phase 2
0.6934 Remote Similarity NPD4908 Phase 1
0.6929 Remote Similarity NPD821 Approved
0.6929 Remote Similarity NPD555 Phase 2
0.6928 Remote Similarity NPD4966 Approved
0.6928 Remote Similarity NPD4965 Approved
0.6928 Remote Similarity NPD4967 Phase 2
0.6918 Remote Similarity NPD5058 Phase 3
0.6917 Remote Similarity NPD1610 Phase 2
0.6912 Remote Similarity NPD257 Approved
0.6912 Remote Similarity NPD258 Approved
0.6908 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6906 Remote Similarity NPD259 Phase 1
0.6897 Remote Similarity NPD8166 Discontinued
0.6894 Remote Similarity NPD7251 Discontinued
0.6894 Remote Similarity NPD4626 Approved
0.6894 Remote Similarity NPD1778 Approved
0.6889 Remote Similarity NPD9634 Clinical (unspecified phase)
0.6889 Remote Similarity NPD8651 Approved
0.6879 Remote Similarity NPD6653 Approved
0.687 Remote Similarity NPD3091 Approved
0.6867 Remote Similarity NPD3455 Phase 2
0.6866 Remote Similarity NPD9269 Phase 2
0.6849 Remote Similarity NPD2677 Approved
0.6838 Remote Similarity NPD3053 Approved
0.6838 Remote Similarity NPD3055 Approved
0.6835 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6831 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6831 Remote Similarity NPD4538 Approved
0.6831 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6831 Remote Similarity NPD4536 Approved
0.6828 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6825 Remote Similarity NPD4750 Phase 3
0.6824 Remote Similarity NPD4123 Phase 3
0.6822 Remote Similarity NPD9618 Approved
0.6822 Remote Similarity NPD9614 Approved
0.6818 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6815 Remote Similarity NPD3685 Discontinued
0.6807 Remote Similarity NPD1809 Phase 2
0.6797 Remote Similarity NPD2801 Approved
0.6794 Remote Similarity NPD16 Approved
0.6794 Remote Similarity NPD856 Approved
0.6791 Remote Similarity NPD422 Phase 1
0.679 Remote Similarity NPD7685 Pre-registration
0.6788 Remote Similarity NPD6584 Phase 3
0.6786 Remote Similarity NPD6233 Phase 2
0.6786 Remote Similarity NPD554 Clinical (unspecified phase)
0.6781 Remote Similarity NPD4110 Phase 3
0.6781 Remote Similarity NPD4628 Phase 3
0.6781 Remote Similarity NPD4109 Clinical (unspecified phase)
0.678 Remote Similarity NPD845 Approved
0.6765 Remote Similarity NPD5311 Approved
0.6765 Remote Similarity NPD5310 Approved
0.6763 Remote Similarity NPD3179 Approved
0.6763 Remote Similarity NPD3180 Approved
0.6763 Remote Similarity NPD7095 Approved
0.6757 Remote Similarity NPD1774 Approved
0.6757 Remote Similarity NPD1511 Approved
0.6748 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6748 Remote Similarity NPD7808 Phase 3
0.6741 Remote Similarity NPD2231 Phase 2
0.6741 Remote Similarity NPD2235 Phase 2
0.6739 Remote Similarity NPD9569 Approved
0.6738 Remote Similarity NPD2238 Phase 2
0.6736 Remote Similarity NPD2161 Phase 2
0.6735 Remote Similarity NPD2219 Phase 1
0.672 Remote Similarity NPD1445 Approved
0.672 Remote Similarity NPD1444 Approved
0.672 Remote Similarity NPD3134 Approved
0.6714 Remote Similarity NPD6798 Discontinued
0.6712 Remote Similarity NPD1652 Phase 2
0.6712 Remote Similarity NPD4162 Approved
0.6711 Remote Similarity NPD4739 Approved
0.671 Remote Similarity NPD3882 Suspended
0.6693 Remote Similarity NPD556 Approved
0.6692 Remote Similarity NPD5691 Approved
0.6691 Remote Similarity NPD5752 Clinical (unspecified phase)
0.6691 Remote Similarity NPD4749 Approved
0.669 Remote Similarity NPD5762 Approved
0.669 Remote Similarity NPD5735 Approved
0.669 Remote Similarity NPD6355 Discontinued
0.669 Remote Similarity NPD4340 Discontinued
0.669 Remote Similarity NPD5763 Approved
0.6688 Remote Similarity NPD5773 Approved
0.6688 Remote Similarity NPD5772 Approved
0.6667 Remote Similarity NPD9616 Approved
0.6667 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6667 Remote Similarity NPD9613 Approved
0.6667 Remote Similarity NPD4108 Discontinued
0.6667 Remote Similarity NPD5960 Phase 3
0.6667 Remote Similarity NPD4062 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data